Header Logo

Connection

TITO R MENDOZA to United States

Back to Details
This is a "connection" page, showing publications TITO R MENDOZA has written about United States.
TITO R MENDOZA
Connection Strength
0.297
United States
  1. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.056
  2. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
    View in: PubMed
    Score: 0.044
  3. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10.
    View in: PubMed
    Score: 0.018
  4. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"? Chest. 2021 07; 160(1):330-340.
    View in: PubMed
    Score: 0.014
  5. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021 02; 18(1):104-114.
    View in: PubMed
    Score: 0.014
  6. The prevalence of altered body image in patients with primary brain tumors: an understudied population. J Neurooncol. 2020 Apr; 147(2):397-404.
    View in: PubMed
    Score: 0.013
  7. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017 06; 158(6):1108-1112.
    View in: PubMed
    Score: 0.011
  8. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):409-418.
    View in: PubMed
    Score: 0.011
  9. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health Qual Life Outcomes. 2016 Feb 19; 14:24.
    View in: PubMed
    Score: 0.010
  10. Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Support Care Cancer. 2016 07; 24(7):2843-51.
    View in: PubMed
    Score: 0.010
  11. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
    View in: PubMed
    Score: 0.010
  12. Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2. J Neurooncol. 2015 Jan; 121(2):341-8.
    View in: PubMed
    Score: 0.009
  13. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.009
  14. Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res. 2014 Feb; 23(1):257-69.
    View in: PubMed
    Score: 0.009
  15. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
    View in: PubMed
    Score: 0.007
  16. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9.
    View in: PubMed
    Score: 0.007
  17. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.007
  18. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010 Mar; 11(3):337-46.
    View in: PubMed
    Score: 0.007
  19. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology. 2009; 76(1):59-68.
    View in: PubMed
    Score: 0.006
  20. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.006
  21. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
    View in: PubMed
    Score: 0.005
  22. The cancer pain experience of Israeli and American patients 65 years and older. J Pain Symptom Manage. 2005 Sep; 30(3):254-63.
    View in: PubMed
    Score: 0.005
  23. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
    View in: PubMed
    Score: 0.005
  24. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-284.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.